Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells - Concepedia

Concepedia

Publication | Open Access

Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells

DOI Full Paper Access

104

Citations

42

References

2008

Year

Panagiotis Karagiannis, Josef Singer, James Hunt, Samuel Ken‐En Gan, Sarah Maria Rudman, Diana Mechtcheriakova, Regina Knittelfelder, Tracy R. Daniels‐Wells, Philip Hobson, Andrew J. Beavil,

Cancer Immunology Immunotherapy

Tumor ImmunologyEffector Cell MechanismsHer2/neu-positive Tumour CellsCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorAntibody EngineeringImmunotherapyMedicineCell BiologyTumor Biology

References

	Year	Citations

Page 1

Page 1